Exploring γH2AX as a key biomarker for DNA...
Exploring γH2AX as a key biomarker for DNA Damage in cancer therapy. Phosphorylation of H2AX at Serine 139 signals DNA double-strand breaks, resulting in...
News & Events
From attending international conferences, to celebrating important scientific milestones, visit this hub to stay up to date with all things Epistem.
Epistem to exhibit at the AACR 2024
April 7-10, 2024 San Diego Convention Center, California Come and meet the Epistem Team at Booth 1219! We’re excited to connect with you at the...
Flashback to 2023!
There have been significant advancements in 2023, aligned with the models performed at Epistem. Our dedicated scientific team always reviews the latest standout publications...
AACR Annual Meeting 2023 Round-up!
AACR Annual Meeting 2023 Round-up! 16th to 19th April · Orange County Convention Center, Orlando Our Oncology Experts attended the AACR Annual Meeting 2023 to...
Epistem to exhibit at the AACR 2023
April 16-19, 2023 Orange County Convention Center in Orlando, Florida Come and meet the Epistem Team at Booth 2464! We're excited to connect with you...
Epistem licenses Hubrecht Organoid Technology
Epistem Limited, a UK-based pre-clinical and clinical research services company, has expanded its in vitro model portfolio through an agreement with Hubrecht Organoid Technology (HUB). The...